Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Yin and yang of interleukin-17 in host immunity to infection.

Das S, Khader S.

F1000Res. 2017 May 23;6:741. doi: 10.12688/f1000research.10862.1. eCollection 2017. Review.

2.

Defective natural killer cell activity in a mouse model of eczema herpeticum.

Kawakami Y, Ando T, Lee JR, Kim G, Kawakami Y, Nakasaki T, Nakasaki M, Matsumoto K, Choi YS, Kawakami T.

J Allergy Clin Immunol. 2017 Mar;139(3):997-1006.e10. doi: 10.1016/j.jaci.2016.06.034. Epub 2016 Jul 29.

PMID:
27476888
3.

Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.

Findlay F, Proudfoot L, Stevens C, Barlow PG.

Pathog Glob Health. 2016 Jun-Jul;110(4-5):137-47. doi: 10.1080/20477724.2016.1195036. Epub 2016 Jun 17. Review.

4.

CD117+ Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide.

Zhou S, Tanaka K, O'Keeffe M, Qi M, El-Assaad F, Weaver JC, Chen G, Weatherall C, Wang Y, Giannakopoulos B, Chen L, Yu D, Hamilton MJ, Wensing LA, Stevens RL, Krilis SA.

PLoS One. 2016 Mar 16;11(3):e0151638. doi: 10.1371/journal.pone.0151638. eCollection 2016.

5.

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

Knitlova J, Hajkova V, Voska L, Elsterova J, Obrova B, Melkova Z.

PLoS One. 2014 Dec 8;9(12):e114374. doi: 10.1371/journal.pone.0114374. eCollection 2014.

6.

Cytokine production associated with smallpox vaccine responses.

Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA.

Immunotherapy. 2014;6(10):1097-112. doi: 10.2217/imt.14.72. Review.

7.

IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.

Gosmann C, Mattarollo SR, Bridge JA, Frazer IH, Blumenthal A.

J Immunol. 2014 Sep 1;193(5):2248-57. doi: 10.4049/jimmunol.1400216. Epub 2014 Jul 25.

8.

CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Goulding J, Abboud G, Tahiliani V, Desai P, Hutchinson TE, Salek-Ardakani S.

J Immunol. 2014 Jun 1;192(11):5415-25. doi: 10.4049/jimmunol.1400256. Epub 2014 Apr 18.

9.

IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum.

Darling AR, Freyschmidt EJ, Burton OT, Koleoglou KJ, Oyoshi MK, Oettgen HC.

Clin Immunol. 2014 Feb;150(2):153-60. doi: 10.1016/j.clim.2013.11.010. Epub 2013 Nov 27.

10.

Pathological role of interleukin-17 in poly I:C-induced hepatitis.

He J, Lang G, Ding S, Li L.

PLoS One. 2013 Sep 19;8(9):e73909. doi: 10.1371/journal.pone.0073909. eCollection 2013.

11.

Staphylococcal and streptococcal superantigen exotoxins.

Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DY, Schlievert PM.

Clin Microbiol Rev. 2013 Jul;26(3):422-47. doi: 10.1128/CMR.00104-12. Review.

12.

Mast cells are required for full expression of allergen/SEB-induced skin inflammation.

Ando T, Matsumoto K, Namiranian S, Yamashita H, Glatthorn H, Kimura M, Dolan BR, Lee JJ, Galli SJ, Kawakami Y, Jamora C, Kawakami T.

J Invest Dermatol. 2013 Dec;133(12):2695-705. doi: 10.1038/jid.2013.250. Epub 2013 Jun 10. Erratum in: J Invest Dermatol. 2015 Mar;135(3):925.

13.

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.

Dobrzanski MJ.

Front Oncol. 2013 Mar 26;3:63. doi: 10.3389/fonc.2013.00063. eCollection 2013.

14.

NK cells and poxvirus infection.

Burshtyn DN.

Front Immunol. 2013 Jan 28;4:7. doi: 10.3389/fimmu.2013.00007. eCollection 2013.

15.

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.

Crickard L, Babas T, Seth S, Silvera P, Koriazova L, Crotty S.

PLoS One. 2012;7(11):e48706. doi: 10.1371/journal.pone.0048706. Epub 2012 Nov 2.

16.

Attenuation of an adult T-cell leukemia skin lesion after treatment of a concomitant herpes simplex infection: a case study.

Tomita H, Ogawa F, Kuwatsuka S, Toriyama F, Yasumoto S, Kamihira S, Utani A.

Virol J. 2012 Oct 1;9:224. doi: 10.1186/1743-422X-9-224.

17.

CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.

Goulding J, Bogue R, Tahiliani V, Croft M, Salek-Ardakani S.

J Immunol. 2012 Sep 1;189(5):2432-40. doi: 10.4049/jimmunol.1200799. Epub 2012 Jul 23.

18.

Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders.

Seedhom MO, Mathurin KS, Kim SK, Welsh RM.

J Virol. 2012 Jun;86(11):6010-22. doi: 10.1128/JVI.07176-11. Epub 2012 Mar 21.

19.

Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Domenico J, Lucas JJ, Fujita M, Gelfand EW.

Int Arch Allergy Immunol. 2012;158(2):196-205. doi: 10.1159/000330647. Epub 2012 Jan 26.

20.

Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, Di Nardo A.

J Immunol. 2012 Jan 1;188(1):345-57. doi: 10.4049/jimmunol.1101703. Epub 2011 Dec 2.

Supplemental Content

Support Center